Dergiler / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 3

Preoperative and intraoperative factors affecting mortality in patients operated on for peptic ulcer perforation: a single center retrospective study

Sayfa
344–348
Yayın Tarihi
2021-05-21
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Understanding these factors, identifying patients at risk, and early intervention can help reduce mortality in PUP.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Peptic ulcer perforation (PUP) is currently the most common complication of peptic ulcer disease (PUD), which requires surgery.
📊
Temel Bulgular & Veri:Mortality and morbidity rates are high after surgical treatment.
💡
Sonuç & Katkı:Understanding these factors, identifying patients at risk, and early intervention can help reduce mortality in PUP.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Peptic ulcer perforation · mortality · peptic ulcer disease

Abstract

Aim: Peptic ulcer perforation (PUP) is currently the most common complication of peptic ulcer disease (PUD), which requires surgery. Mortality and morbidity rates are high after surgical treatment. The aim of this study was to determine the predictive factors affecting postoperative mortality in patients undergoing surgery due to peptic ulcer perforation. Methods: The study included 135 patients diagnosed and operated on because of PUP in the general surgery clinic between February 2015 and January 2020. Evaluations were made of the relationships between mortality and age, gender, ASA scores, season of surgery, preoperative leukocyte, preoperative neutrophil to lymphocyte ratio (NLR), preoperative creatinine and amylase values, location and diameter of the perforation, comorbid diseases, onset of pain and time of surgery. Results: Advanced age, male gender, high ASA score, >12 hours between the onset of the symptoms and the time of surgery, and high creatinine, NLR and amylase values before surgery, ulcer diameter >1 cm and comorbid diseases were associated with mortality. No relationship was found between the location of the ulcer and leukocyte values at the time of admission and mortality. Conclusion: Advanced age, male gender, high ASA score, >12 hours between the onset of symptoms and the time of surgery, and high preoperative creatinine, NLR and amylase values, ulcer diameter >1 cm and comorbid diseases are risk factors for mortality in peptic ulcer perforation. Understanding these factors, identifying patients at risk, and early intervention can help reduce mortality in PUP.

🔖

Bu Makaleye Atıf Yap

ŞENLİKCİ, A., KOŞMAZ, K., DURHAN, A., MERCAN, Ü., SÜLEYMAN, M. (2021). Preoperative and intraoperative factors affecting mortality in patients operated on for peptic ulcer perforation: a single center retrospective study. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 3, 344–348. https://ajindex.com/articles/776942

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Zelickson MS, Bronder CM, Johnson BL, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation.Am Surg 2011; 77: 1054–60.
  2. Thorsen K, Glomsaker TB, von Meer A, Søreide K, Søreide JA. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. J Gastrointest Surg 2011; 15: 1329–35.
  3. Tanrikulu Y, Tanrikulu CS, Sabuncuoglu MZ, Kokturk F, Temi V, Bicakci E. Is the neutrophil-to-lymphocyte ratio a potential diagnostic marker for peptic ulcer perforation? A retrospective cohort study. Am J Emerg Med 2016; 34: 403–6.
  4. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011; 84: 102–13.
  5. Koçer B, Sürmeli S, Solak C, et al. Factors affecting mortality and morbidity in patients with peptic ulcer perforation. J Gastroenterol Hepatol 2007; 22: 565–70.
  6. Sarosi GA, Jaiswal KR, Nwariaku FE, Asolati M, Fleming JB, Anthony T. Surgical therapy of peptic ulcers in the 21st century: more common than you think. Am J Surg 2005; 190: 775-9.
  7. Chalya PL, Mabula JB, Koy M, et al. Clinical profile and outcome of surgical treatment of perforated peptic ulcers in Northwestern Tanzania: A tertiary hospital experience. World J Emerg Surg 2011; 6: 31. Lohsiriwat V, Prapasrivorakul S, Lohsiriwat D. Perforated peptic ulcer: clinical presentation, surgical outcomes, and the accuracy of the Boey scoring system in predicting postoperative morbidity and mortality. World J Surg 2009; 33: 80–5.
  8. Zittel TT, Jehle EC, Becker HD. Surgical management of peptic ulcer disease todayindication, technique and outcome. Langenbecks Arch Surg 2000; 385: 84–96. Mäkelä J, Laitinen S, Kairaluoma MI. Complications of peptic ulcer disease before and after the introduction of H2 receptor antagonists. Hepatogastroenterology 1992; 39: 144–8.
  9. Casali JJ, Franzon O, Kruel NF, Neves BD. Epidemiological analysis and use of rapid urease test in patients with perforated peptic ulcers. Rev Col Bras Cir 2012; 39: 93–8. Søreide K, Thorsen K, Harrison EM, Bingener J, Moller MH, Ohene-Yeboah M. Perforated peptic ulcer. Lancet 2015; 386: 1288–98.
  10. Sivaram P, Sreekumar A. Preoperative factors influencing mortality and morbidity in peptic ulcer perforation. Eur J Trauma Emerg Surg 2018; 44: 251–7.
  11. Aydın O, Pehlivanlı F. Is the Platelet to lymphocyte ratio a potential biomarker for predicting mortality in peptic ulcer perforation? Surg